375 related articles for article (PubMed ID: 29155069)
1. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
[TBL] [Abstract][Full Text] [Related]
4. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.
Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F
J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y
Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625
[TBL] [Abstract][Full Text] [Related]
7. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
9. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
10. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract][Full Text] [Related]
11. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
12. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.
Zhang L; Cai JQ; Zhao JJ; Bi XY; Tan XG; Yan T; Li C; Zhao P
J Surg Oncol; 2010 Mar; 101(3):233-8. PubMed ID: 20169539
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
15. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ
Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361
[TBL] [Abstract][Full Text] [Related]
19. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
20. Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma.
Lu WF; Chen PQ; Yan K; Wu YC; Liang L; Yuan JY; Fu Y; Zhang HB
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):575-582. PubMed ID: 33899638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
